January 07, 2025 05:47 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Delhi assembly elections on Feb 5, results on Feb 8 | Allu Arjun visits boy injured during Pushpa 2 stampede in Hyderabad | Donald Trump repeats his US-Canada merger offer after Justin Trudeau's resignation | India's HMPV cases surge to 7 after two cases reported from Nagpur | H-1B visa renewal will get simpler in 2025, Indians to benefit most as home country travel won't be required | As India detects 3 HMPV cases, #lockdown trends; Centre says no need to panic | Justin Trudeau announces resignation as Canada's PM amid rising pressure by partymates | 8 jawans, driver killed as Maoists blow up security vehicle in Chhattisgarh's Bijapur | Atul Subhash suicide: Karnataka High Court refuses to quash FIR against wife Nikita Singhania | Delhi elections: Congress launches Pyari Didi scheme promising Rs. 2,500 per month to women residents
Merck and Ridgeback’s Molnupiravir medicine demonstrates activity against Omicron variant

Merck and Ridgeback’s Molnupiravir medicine demonstrates activity against Omicron variant

Jan 29, 2022, at 03:49 pm

New Jersey: Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics has announced data from six preclinical studies demonstrating that molnupiravir, an investigational oral antiviral COVID-19 medicine, was active against the SARS-CoV-2 variant Omicron (B1.1.529) in vitro.

Merck's Covid pill Molnupiravir out of national treatment protocol for 'major safety concerns': ICMR

Merck's Covid pill Molnupiravir out of national treatment protocol for 'major safety concerns': ICMR

Jan 06, 2022, at 04:36 am

New Delhi/IBNS: Indian Council for Medical Research (ICMR) has cited 'major safety concerns' for not adding Merck's coronavirus pill, Molnupiravir, to the national treatment protocol.

Indian drugs regulator seeks more info on Merck's Covid-19 pill

Indian drugs regulator seeks more info on Merck's Covid-19 pill

Nov 19, 2021, at 10:15 pm

New Delhi/IBNS: Indian drug regulator CDSCO's expert panel has sought additional data from the companies seeking emergency use authorisation (EUA) for MSD's Covid-19 antiviral medication molnupiravir, media reports said.

UK becomes first country to approve Merck's Covid-19 pill molnupiravir: Report

UK becomes first country to approve Merck's Covid-19 pill molnupiravir: Report

Nov 05, 2021, at 02:34 am

London/IBNS: Britain on Thursday became the first country to approve COVID-19 antiviral pill jointly developed by U.S.-based Merck and Ridgeback Biotherapeutics, media reports said.